Who owns PTXTQ - PERNIX THERAPEUTICS HLDGS IN - COM NEW based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) Institutional Ownership

Q: What is CUSIP 71426V306?

CUSIP 71426V306 is the security identifier used in SEC filing datasets for PTXTQ - PERNIX THERAPEUTICS HLDGS IN - COM NEW.

CUSIP: 71426V306

13F Institutional Holders and Ownership History from Q3 2016 to Q1 2019

Type / Class: Equity / COM NEW
Symbol: PTXTQ

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 71426V306?
CUSIP 71426V306 identifies PTXTQ - PERNIX THERAPEUTICS HLDGS IN - COM NEW in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 71426V306:

Q1 2019 (0 holders) Q4 2018 (20 holders) Q3 2018 (19 holders) Q2 2018 (16 holders) Q1 2018 (20 holders) Q4 2017 (18 holders) Q3 2017 (23 holders) Q2 2017 (23 holders) Q1 2017 (20 holders) Q4 2016 (22 holders)

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2019 Q1	0	$0	-$933,419	$0	$0		0
2018 Q4	2,224,110	$933,420	-$810,300	$11,000	$17,000	$0.42	20
2018 Q3	2,982,828	$2,872,963	+$832,609	$84,000	$27,000	$0.96	19
2018 Q2	2,077,629	$5,045,430	+$119,937	$244,000	$133,000	$2.43	16
2018 Q1	2,029,466	$4,849,390	+$22,252	$45,000	$38,000	$2.39	20
2017 Q4	2,019,656	$4,845,400	+$182,047	$79,000	$76,000	$2.40	18
2017 Q3	1,932,632	$6,084,150	+$97,831	$104,000	$177,000	$3.14	23
2017 Q2	1,972,774	$7,929,020	+$998,681	$1,376,000	$1,071,000	$4.02	23
2017 Q1	1,728,038	$6,393,000	+$471,002	$1,001,000	$836,000	$3.70	20
2016 Q4	1,971,149	$3,824,000	+$3,378,447	$38,000	$34,000	$1.94	22
2016 Q3	249,723	$155,000	+$155,000			$0.61	4